About the job
About Ataraxis AI
Ataraxis AI is at the cutting edge of AI-driven precision medicine, specializing in the integration of multi-modal artificial intelligence with oncology. Our innovative AI-native tools are designed to empower physicians in choosing the ideal treatment pathways for their patients.
We are on a mission to revolutionize cancer care, aiming to transform the treatment landscape for at least 50% of new cancer patients by 2030. Our pioneering test for breast cancer, developed through a validation study involving over 8,000 patients from 15 leading institutions worldwide, enhances the accuracy of standard tests by 30%, facilitating an annual testing capacity for 100,000 new patients. Joining Ataraxis means you will have a unique opportunity to influence not just our company's direction, but also the future of healthcare.
Ataraxis boasts a dynamic team of experts at the forefront of AI research and its application in healthcare. Our lab merges the expertise of top AI researchers, medical professionals, and industry veterans, including renowned AI figures like Yann LeCun and distinguished oncologists from premier cancer research centers, all committed to reshaping precision medicine.
We have successfully secured $24 million in funding, highlighted by a $20.4 million Series A round led by prestigious venture capital firms such as AIX Ventures (Hugging Face, Perplexity), Thiel Capital, Founders Fund (OpenAI, SpaceX, Palantir, Oscar Health), and Obvious Ventures (Recursion). Our journey has been featured in a notable TechCrunch article, "Not all cancer patients need chemo."
As an AI-native organization, we embrace a flat structure that empowers every team member to contribute proactively. Leadership is granted based on initiative and consistent outstanding performance, with a strong work ethic and the ability to prioritize effectively being crucial.

